Cargando…
Carcinoid Tumor: Advances in Treatment Options
Small bowel neoplasms are rare, accounting for only 3%-6% of all gastrointestinal neoplasms. Carcinoid tumors represent a large portion of these (20%-30%), making them the second most common small bowel malignancy after adenocarcinoma. Gastrointestinal carcinoids constitute 70% of all neuroendocrine...
Autores principales: | Vusqa, Urwat T, Patel, Stuti, Rashid, Mamoon Ur, Sarvepalli, Deepika, Khan, Abu H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011579/ https://www.ncbi.nlm.nih.gov/pubmed/32064213 http://dx.doi.org/10.7759/cureus.6641 |
Ejemplares similares
-
Postsurgical Refractory Gastroparesis: Response to Botulinum Toxin Therapy
por: Sarvepalli, Deepika, et al.
Publicado: (2020) -
A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine
por: Malayala, Srikrishna V, et al.
Publicado: (2021) -
Focal Active Colitis Presented With Chronic Diarrhea
por: Mandzhieva, Bayarmaa, et al.
Publicado: (2020) -
Gastric Carcinoid: The Invisible Tumor!
por: Dhruv, Samyak, et al.
Publicado: (2021) -
Coronavirus Disease 2019: A Comprehensive Review of Etiology, Pathogenesis, Diagnosis, and Ongoing Clinical Trials
por: Sarvepalli, Deepika
Publicado: (2020)